Virios Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 1.29 million compared to USD 1.52 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.08 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2382 USD | +2.67% |
|
+4.47% | -58.57% |
May. 20 | Top Midday Decliners | MT |
May. 20 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Ahead of NVIDIA Earnings due Wednesday | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.57% | 6.61M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- VIRI Stock
- News Virios Therapeutics, Inc.
- Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024